Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Cash from Investing Activities (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Cash from Investing Activities for 3 consecutive years, with $491000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities changed N/A to $491000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$597000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at -$374000.0 for FY2025, N/A changed from the prior year.
  • Cash from Investing Activities for Q4 2025 was $491000.0 at Adagio Medical Holdings, up from -$335000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $491000.0 in Q4 2025, with the low at -$578000.0 in Q3 2024.
  • Average Cash from Investing Activities over 3 years is -$129833.3, with a median of -$168500.0 recorded in 2024.
  • Peak annual rise in Cash from Investing Activities hit 106.79% in 2025, while the deepest fall reached 106.79% in 2025.
  • Over 3 years, Cash from Investing Activities stood at -$20000.0 in 2023, then plummeted by 2790.0% to -$578000.0 in 2024, then skyrocketed by 184.95% to $491000.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $491000.0, -$335000.0, and -$578000.0 for Q4 2025, Q1 2025, and Q3 2024 respectively.